Skip to main content
Clinical Trials/NCT05233111
NCT05233111
Enrolling By Invitation
Not Applicable

Prevention of Posttraumatic Stress: A RCT of Modified Brief Prolonged Exposure Therapy (Brief PE) During Inpatient Rehabilitation Post Spinal Cord Injury (SCI)

Baylor Research Institute1 site in 1 country200 target enrollmentFebruary 7, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Spinal Cord Injuries
Sponsor
Baylor Research Institute
Enrollment
200
Locations
1
Primary Endpoint
Change in PSSI-5: PTSD Symptom Scale - Interview for DSM-5
Status
Enrolling By Invitation
Last Updated
3 months ago

Overview

Brief Summary

This study will examine the use brief prolonged exposure (Brief PE) therapy compared to standard clinical care to reduce posttraumatic distress among people who have had a spinal cord injury and are receiving rehabilitation in an inpatient setting.

Detailed Description

This is a prospective randomized controlled trial examining the efficacy of brief Prolonged Exposure Therapy (Brief PE) delivered in an inpatient rehabilitation setting post-SCI to reduce PTSD symptoms. The overall goal of this project is to test a Brief PE (three 60-minute sessions) to reduce psychological distress after SCI and to mitigate long-term post-SCI distress including PTSD as well as secondary health outcomes (including depression and general anxiety) at 1, 3, and 6 months from baseline. The intervention group (Brief PE) will be compared to standard clinical care with treatment as usual (TAU).

Registry
clinicaltrials.gov
Start Date
February 7, 2022
End Date
August 1, 2026
Last Updated
3 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • 18 years of age or older
  • Admitted to the inpatient rehabilitation hospital diagnosed with a SCI following a traumatic event

Exclusion Criteria

  • Patients in police custody
  • Not fluent in the English language
  • Severe cognitive impairment
  • Patients who are acutely suicidal
  • Patients with active psychosis

Outcomes

Primary Outcomes

Change in PSSI-5: PTSD Symptom Scale - Interview for DSM-5

Time Frame: Baseline, 1 month, 3 months ,6 months

Change in PTSD symptoms from baseline to 6 months. Total scale ranges from 0-80 points. Higher score indicates greater severity of symptoms.

Secondary Outcomes

  • Change in Generalized Anxiety Disorder-7 Item(Time Frame: Baseline, 1 month, 3 months, 6 months)
  • Change in Patient Health Questionnaire-9(Baseline, 1 month, 3 months ,6 months)

Study Sites (1)

Loading locations...

Similar Trials